HiberGen raises €3.8m from Trinity Biotech

Irish genomics company HiberGen has raised €3.8m in follow-on investment from Trinity Biotech.

Irish genomics company HiberGen has raised €3.8m in follow-on investment from Trinity Biotech.

Trinity Biotech was the key initial investor in HiberGen and is exercising its option to re-invest.

You have reached your article limit. Already a subscriber? Sign in

Save €40 on an Annual Subscription.​

Continue reading within unlimited digital access and exclusive subscriber benefits.

Cancel anytime

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited